New publications
|
Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson’s Disease: A Randomized, Placebo-Controlled, Phase 1 Study Werner Poewe, Dieter Volc, Klaus Seppi, Rossella Medori, Petra Lührs, Alexandra Kutzelnigg, Atbin Djamshidian, Caroline Thun-Hohenstein, Wassilios G. Meissner, Olivier Rascol, Achim Schneeberger, Günther Staffler, Roberto deMarzi, Beatrice Heim, Stephanie Mangesius, Raphaela Stolz, Katarzyna Wachowicz, Constanze Riha, Vera Bürger, Gergana Galabova,. JPD. 2021-08-02. 11(3): 1079-1089. 10.3233/JPD-212594
|
Serum miR-96-5P and miR-339-5P Are Potential Biomarkers for Multiple System Atrophy and Parkinson’s Disease Annamaria Vallelunga, Tommaso Iannitti, Sabrina Capece, Gerardina Somma, Maria Claudia Russillo, Alexandra Foubert-Samier, Brice Laurens, Igor Sibon, Wassilios G. Meissner, Paolo Barone, Maria Teresa Pellecchia. Front. Aging Neurosci.. 2021-07-26. 10.3389/fnagi.2021.632891
|
Nicotine inhibits the VTA-to-amygdala dopamine pathway to promote anxiety. Claire Nguyen, Sarah Mondoloni, Tinaïg Le Borgne, Ines Centeno, Maxime Come, Joachim Jehl, Clément Solié, Lauren M. Reynolds, Romain Durand-de Cuttoli, Stefania Tolu, Sébastien Valverde, Steve Didienne, Bernadette Hannesse, Jean-François Fiancette, Stéphanie Pons, Uwe Maskos, Véronique Deroche-Gamonet, Deniz Dalkara, Jean-Pierre Hardelin, Alexandre Mourot, Fabio Marti, Philippe Faure. Neuron. 2021-07-01. 10.1016/j.neuron.2021.06.013
|
|
|
|